Somatic mutations of the L12a gene in V-κ1 light chain deposition disease: Potential effects on aberrant protein conformation and deposition

American Journal of Pathology

Volumn 155, Issue 6, 1999, Pages 2009-2017

  Vidal, Ruben ^a   Goñi, Fernando ^a,b   Stevens, Fred ^c   Aucouturier, Pierre ^a,d   Kumar, Asok ^a   Frangione, Blas ^a   Ghiso, Jorge ^a   Gallo, Gloria ^a,e  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSIDAD DE LA REPÚBLICA   (Uruguay)

^c ARGONNE NATIONAL LABORATORY   (United States)

^d HÔPITAL NECKER ENFANTS MALADES   (France)

^e NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN LIGHT CHAIN;

ADULT; AMINO ACID SEQUENCE; AMYLOIDOSIS; ARTICLE; CASE REPORT; CELL PROLIFERATION; CELL ULTRASTRUCTURE; CLONAL ANERGY; FEMALE; GENETIC DISORDER; HUMAN; HYDROPHOBICITY; ISOELECTRIC FOCUSING; KIDNEY BIOPSY; MOLECULAR CLONING; PRIORITY JOURNAL; PROTEIN FOLDING; SOMATIC MUTATION;

EID: 0344146434     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65520-4     Document Type: Article

References (39)

1. Gallo G, Picken M, Buxbaum J, Frangione B: The spectrum of monoclonal immunoglobulin deposition disease associated with immunocytic dyscrasias. Semin Hematol 1989, 3:234-245
2. Gallo G, Wisniewski T, Choi-Miura NH, Ghiso J, Frangione B: Potential role of apolipoprotein E in fibrillogenesis. Am J Pathol 1994, 145:526-530
3. Lyon AW, Narindrasorasak S, Young ID, Anastassiades T, Couchman JR, McCarthy KJ, Kisilevsky R: Co-deposition of basement membrane components during the nduction of murine splenic AA amyloid. Lab Invest 1991, 64:785-790
4. Randall RE, Williamson WC Jr, Mulinax F, Tung MY, Still MJ: Manifestations of systemic light chain deposition. Am J Med 1976, 60:293-299
5. Ganeval D, Mignon F, Preud'homme JL, Noel L-H, Morel-Maroger L, Droz D, Brouet JC, Mery J, Grunfeld J-P: Visceral deposition of monoclonal light chains and immunoglobulins: a study of renal and immunopathologic abnormalities. Adv Nephrol 1982, 11:25-63
6. Cogne M, Preud'homme JL, Bauwens M, Touchard G, Aucouturier P: Structure of a monoclonal κ chain of the V-κIV subgroup in the kidney and plasma cells in light chain deposition disease. J Cl n Invest 1991, 87:2186-2190
7. Bellotti V, Stoppini M, Merlini G, Zapponi MC, Meloni ML, Banfi G, Ferri G: Amino acid sequence of κ Sci, the Bence Jones protein isolated from a patient with light chain deposition disease. Biochim Biophys Acta 1991, 1097:177-182
8. Khamlichi AA, Aucouturier P, Silvain C, Bauwens M, Touchard G, Preud'homme J-L, Nau F, Cogne M: Primary structure of a monoclonal κ chain in myeloma with light chain deposition disease. Clin Exp Immunol 1992, 87:122-126
9. 1 subgroup (ISE) in light chain deposition disease. Clin Exp Immunol 1993, 91:506-509
10. IH immunoglobulin light chain in myeloma with light chain deposition disease. Clin Exp Immunol 1996, 106:357-361
11. Gallo G, Goni F, Boctor F, Vidal R, Kumar A, Stevens FJ, Frangione B, Ghiso J: Light chain cardiomyopathy: structural analysis of the light chain tissue deposits. Am J Pathol 1996, 148:1397-1406
12. Decourt C, Touchard G, Preud'homme J-L, Vidal R, Beaufils H, Diemert M-C, Cogne M Complete primary sequences of two λ immunoglobulin light chains in myelomas with nonamyloid (Randall-type) light chain deposition disease. Am J Pathol 1998, 153:313-318
13. Stevens FJ, Weiss DT, Solomon A: Structural bases of light chain-related pathology. The Antibodies, vol 5 Edited by M Zanetti and JD Capra. Amsterdam, Harwood Academic Publishers, 1999. pp 175-208
14. Kaplan B, German G, Pras M: Isolation and characterization of amyloid proteins from milligram amounts of amyloid-containing tissue. J Liq Chromatogr 1993, 16:249-268
15. Kaplan B, Yakar S, Kumar A, Pras M, Gallo G: Immunochemical characterization of amyloid in diagnostic biopsy tissues. Amyloid Int J Exp Clin Invest 1997, 4:80-86
16. Gallo G, Feiner H, Chuba J, Beneck D, Marion P, Cohen DH: Characterization of tissue amyloid by immunofluorescence microscopy. Clin Immunol Immunopathol 1986, 39:479-490
17. Kabat EA, Wu TT, Perry HM, Gottesman KS, Foeller C: Human κ Light Chain Subgroup I. Sequences of Proteins of Immunological Interest. Bethesda, MD. National Institutes of Health, 1991, pp 103-112
18. Epp O, Lattman EF, Schiffer M, Huber R, Palm W: The molecular structure of a dimer composed of the variable portions of the Bence-Jones protein REI refined at 2.0-A resolution Biochemistry 1975, 14:4943-4952
19. Choathia C, Lesk AM: Canonical structure for the hypervariable regions of the immunoglobulins. J Mol Biol 1987, 196:901-917
20. Skoog B, Wichman A: Calculation of the isoelectric points of polypeptides from the amino-acid composition. Trends Anal Chem 1986, 82-83
21. Klein R, Jaenichen R, Zachau HG: Expressed human immunoglobulin κ genes and their hypermutation. Eur J Immunol 1993, 23:3248-3271
22. Kanwar YS, Farquhar MG: Presence of heparan sulfate in glomerular basement membrane. Proc Natl Acad Sci USA 1979, 76:1303-1307
23. Gallo GR, Caulin-Glaser T, Lamm ME: Charge of circulating immune complexes as a factor in glomerular basement membrane localization in mice. J Clin Invest 1981, 67:1305-1307
24. Bellotti V, Merlini G, Bucciarelli E, Perfetti V, Quaglini S, Ascari E: Relevance of class, molecular weight and isoelectric point in predicting human light chain amyloidogenicity. Br J Haematol 1990, 74: 65-69
25. Kaplan B, Vidal R, Kumar A, Ghiso J, Frangione B, Gallo G: Aminoterminal identity of co-existent amyloid and non-amyloid immunoglobulin κ light chain deposits. A human disease to study alterations of protein conformation. Clin Exp Immunol 1997, 110:472-478
26. Klafki H-W, Kratzin HD, Pick AI, Eckart K, Karas M, Hilschmann N: Complete amino acid sequence determinations demonstrate identity of the urinary Bence Jones protein (BJP-DIA) and the amyloid fibril protein (AL-DIA) in a case of AL-amyloidosis. Biochemistry 1992, 31:3265-3272
27. Soto C, Frangione B: Two conformational states of amyloid β-peptide: implication for the pathogenesis of Alzheimer's disease. Neurosci Lett 1995, 186:115-118
28. Jimenez JL, Guijarro JI, Orlova E, Zurdo J, Dobson CM, Sunde M, Saibil HR Cryo-electron microscopy structure of an SH3 amyloid fibril and model of the molecular packing. EMBO J 1999, 18:815-821
29. Chiti F, Webster P, Taddei N, Clark A, Stefani M, Ramponi G, Dobson CM: Designing conditions for in vitro formation of amyloid protofilaments and fibrils. Proc Natl Acad Sci USA 1999, 96:3590-3594
30. Soto C, Ghiso J, Frangione B: Alzheimer's amyloid β aggregation is modulated by the interaction of multiple factors. Alzheimer's Res 1997, 3:215-222
31. Carrell RW, Lomas DA: Conformational disease. Lancet 1997, 350: 134-138
32. Hurle MR, Helms LR, Li L, Chan W, Wetzel R: A role for destabilizing amino acid replacements in light chain amyloidosis. Proc Natl Acad Sci USA 1994, 91:5446-5450
33. Deret S, Chomiier J, Huang DB, Preud'homme J-L, Stevens FJ, Aucouturier P: Molecular modeling cf immunoglobulin light chains implicates hydrophobic residues in non-amyloid light chain deposition disease. Protein Eng 1997, 10:1191-1197
34. Raffen R, Dieckman LJ, Szpunar M, Wuschl C, Pokkuluri PR, Dave P, Stevens PW, Cai X, Schiffer M, Steven F: Physicochemical consequences of amino acid variations that contribute to fibril formation by immunoglobulin light chains. Protein Sci 1999, 8:509-517
35. Bellotti V, Stopp ni M, Mangione PP, Fornasieri A, Min L, Merlini G, Ferr G: Structural and functional characterization of three human immunoglobulin kappa light chains with different pathologic implications. Biochim Biophys Acta 1996, 1317:161-167
36. Capaldi AP, Ferguson SJ, Radford S: The Greek key protein apopseudoazurin folds through an obligate or-pathway intermediate. J Mol Biol 1999, 286:1621-1632
37. Radford SE, Dobson CM: From computer simulations to human disease: emerging themes in protein folding. Cell 1999, 97:291-298
38. Stokes MB, Jagirdar J, Burchstin O, Kornacki S, Kumar A, Gallo G: Nodular pulmonary immunoglobulin light chain deposits with coexistent amyloid and nonamyloid features in an HIV-infected patient. Mod Pathol 1997, 10:1059-1065
39. He XM, Ruker F, Casale E, Carter DC: Structure of a human monoclonal antibody Fab fragment against gp41 of human immunodeficiency virus type I. Proc Natl Acad Sci USA 1992, 89:7154-7158